Menu

• Ask a Health Expert about POSTRENAL FAILURE
• Post Your Side Effect related to POSTRENAL FAILURE
• POSTRENAL FAILURE and FDA Warnings
• POSTRENAL FAILURE in Patients Wiki
• Report POSTRENAL FAILURE in Drug Side Effect Survey

POSTRENAL FAILURE side effect

What is POSTRENAL FAILURE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prograf Side Effects Report #5348449-7
Physician from JAPAN reported PROGRAF problem on May 22, 2007. Male patient was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: postrenal failure, shock, upper gastrointestinal haemorrhage, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE. Patient died on 03/13/2004.

Prograf Side Effects Report #5370616-7
PROGRAF problem was reported by a Physician from JAPAN on June 13, 2007. Male patient was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, postrenal failure, shock, upper gastrointestinal haemorrhage, . PROGRAF dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, MELPHALAN. Patient died on 03/13/2004.

Zovirax Side Effects Report #5609701-0
Physician from JAPAN reported ZOVIRAX problem on Jan 25, 2008. Male patient, 20 years of age, weighting 110.2 lb, was treated with ZOVIRAX. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dyslalia, postrenal failure, toxic encephalopathy, urinary retention, . ZOVIRAX dosage: 500MG THREE TIMES PER DAY. During the same period patient was treated with MEROPEN, GLYCEOL. Patient recovered.

Vesicare Side Effects Report #5281177-5
VESICARE problem was reported by a Physician from JAPAN on Mar 09, 2007. Male patient, 68 years of age, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, hydronephrosis, postrenal failure, tremor, urinary retention, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with OLMETEC, FLUITRAN, TAKEPRON, HARNAL, BAYASPIRINLET. Patient was hospitalized. Patient recovered.